Ronald Harold Wilfred Cooper's most recent trade in Generation Bio Co was a trade of 6,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Generation Bio Co | Ronald Harold Wilfred Cooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 6,000 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Ronald Harold Wilfred Cooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 3,000 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Ronald Harold Wilfred Cooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 3,000 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Ronald Harold Wilfred Cooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 2,500 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Ronald Harold Wilfred Cooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 1,920 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Ronald Harold Wilfred Cooper | Director | 09 Feb 2026 | 950 | 0 | - | - | Common Stock | ||
| enGene Holdings Inc | Ronald Harold Wilfred Cooper | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 801,000 | 801,000 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Ronald Harold Wilfred Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 35,500 | 35,500 | - | - | Stock Option (Right to Buy) | |
| Generation Bio Co | Ronald Harold Wilfred Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| enGene Holdings Inc | Ronald Harold Wilfred Cooper | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 850,000 | 850,000 | - | - | Stock Option (Right to Buy) |